Virtue Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $270K | Buy |
539
+32
| +6% | +$15.4K | 0.04% | 292 |
|
|
2026
Q1 | $243K | Sell |
507
-12
| -2% | -$6.51K | 0.04% | 283 |
|
|
2025
Q4 | $308K | Sell |
519
-23,895
| -98% | -$13.5M | 0.05% | 239 |
|
|
2025
Q3 | $1.41M | Buy |
24,414
+23,861
| +4,315% | +$11.1M | 0.22% | 68 |
|
|
2025
Q2 | $224K | Sell |
553
-1,032
| -65% | -$431K | 0.04% | 240 |
|
|
2025
Q1 | $789K | Buy |
1,585
+619
| +64% | +$335K | 0.09% | 185 |
|
|
2024
Q4 | $502K | Sell |
966
-762
| -44% | -$419K | 0.1% | 147 |
|
|
2024
Q3 | $1.07M | Sell |
1,728
-104
| -6% | -$61.6K | 0.21% | 72 |
|
|
2024
Q2 | $1.02M | Sell |
1,832
-184
| -9% | -$105K | 0.17% | 100 |
|
|
2024
Q1 | $1.14M | Sell |
2,016
-552
| -21% | -$310K | 0.21% | 92 |
|
|
2023
Q4 | $1.37M | Buy |
2,568
+53
| +2% | +$25.7K | 0.28% | 70 |
|
|
2023
Q3 | $1.31M | Hold |
2,515
| – | – | 0.22% | 83 |
|
|
2023
Q2 | $1.31M | Sell |
2,515
-197
| -7% | -$106K | 0.22% | 83 |
|
|
2023
Q1 | $1.45M | Sell |
2,712
-241
| -8% | -$136K | 0.24% | 72 |
|
|
2022
Q4 | $1.63M | Buy |
2,953
+1,634
| +124% | +$866K | 0.25% | 62 |
|
|
2022
Q3 | $669K | Sell |
1,319
-89
| -6% | -$49.8K | 0.11% | 85 |
|
|
2022
Q2 | $765K | Sell |
1,408
-7,918
| -85% | -$4.36M | 0.12% | 84 |
|
|
2022
Q1 | $5.51M | Sell |
9,326
-1,920
| -17% | -$1.1M | 0.87% | 21 |
|
|
2021
Q4 | $7.5M | Buy |
11,246
+280
| +3% | +$175K | 1.11% | 11 |
|
|
2021
Q3 | $6.26M | Buy |
10,966
+14
| +0.1% | +$7.68K | 1.11% | 12 |
|
|
2021
Q2 | $5.53M | Sell |
10,952
-120
| -1% | -$56.6K | 1.1% | 13 |
|
|
2021
Q1 | $5.05M | Sell |
11,072
-150
| -1% | -$71.6K | 1.19% | 10 |
|
|
2020
Q4 | $5.23M | Sell |
11,222
-622
| -5% | -$292K | 1.28% | 10 |
|
|
2020
Q3 | $5.23M | Buy |
11,844
+1,020
| +9% | +$421K | 1.29% | 12 |
|
|
2020
Q2 | $3.92M | Buy |
+10,824
| New | +$3.63M | 0.9% | 20 |
|
|
2020
Q1 | – | Sell |
-8,212
| Closed | -$2.67M | – | 194 |
|
|
2019
Q4 | $2.67M | Buy |
8,212
+2,511
| +44% | +$761K | 0.77% | 28 |
|
|
2019
Q3 | $1.66M | Buy |
5,701
+2,454
| +76% | +$703K | 0.55% | 59 |
|
|
2019
Q2 | $954K | Buy |
3,247
+2,461
| +313% | +$678K | 0.35% | 93 |
|
|
2019
Q1 | $215K | Buy |
+786
| New | +$196K | 0.08% | 103 |
|
|
2018
Q4 | – | Sell |
-1,068
| Closed | -$261K | – | 221 |
|
|
2018
Q3 | $261K | Buy |
+1,068
| New | +$246K | 0.06% | 224 |
|
|
2018
Q2 | – | Sell |
-617
| Closed | -$133K | – | 438 |
|
|
2018
Q1 | $133K | Sell |
617
-50
| -7% | -$10.5K | 0.07% | 211 |
|
|
2017
Q4 | $127K | Buy |
+667
| New | +$128K | 0.07% | 201 |
|
Other funds holding TMO
Virtue Capital Management's TMO Position: Q2 2026 in Review
Virtue Capital Management increased its Thermo Fisher Scientific (TMO) stake by 6.3% in Q2 2026, buying an estimated $15.4K and bringing the position to 539 shares worth $270K. The position accounts for 0.04% of the portfolio, ranked #292.
Virtue Capital Management first reported a position in TMO in Q4 2017 and has held it in 32 quarters since. The position peaked at $7.5M in Q4 2021. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Virtue Capital Management held 539 shares of Thermo Fisher Scientific worth $270K as of Q2 2026.
- Virtue Capital Management bought 32 Thermo Fisher Scientific shares in Q2 2026, an estimated $15.4K.
- Thermo Fisher Scientific made up 0.04% of Virtue Capital Management's portfolio in Q2 2026, its #292 holding.
- Virtue Capital Management first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 32 quarters since.
- Virtue Capital Management's Thermo Fisher Scientific position peaked at $7.5M in Q4 2021.
- 1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Virtue Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.